CEP 5214

Known as: CEP-5214, CEP5214 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2006
012320032006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
CEP-7055, a fully synthetic, orally active N,N-dimethylglycine ester of CEP-5214, a C3-(isopropylmethoxy)-fused pyrrolocarbazole… (More)
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2003
2003
Inhibition of the vascular endothelial growth factor VEGF-VEGF receptor (VEGF-R) kinase axes in the tumor angiogenic cascade is a… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
A series of potent vascular endothelial growth factor R2 (VEGF-R2) tyrosine kinase inhibitors from a new indenopyrrolocarbazole… (More)
Is this relevant?
2003
2003
Inhibition of the vascular endothelial growth factor VEGF-VEGF receptor (VEGF-R) kinase axes in the tumor angiogenic cascade is a… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?